New method developed for delivering drugs to the brain, says study
Published 21 March 2011
Scientists have developed a new way of administering drugs to the brain to treat Alzheimer’s disease, according to a study published on Sunday 20 March 2011 in ‘Nature Biotechnology’.
This new technology was also found to reduce the production of the enzyme BACE1, which helps produce the plaques in the brain in Alzheimer's disease.
Alzheimer's Society comment:
'In this exciting study, researchers may have overcome a major barrier to the delivery of potential new drugs for many neurological diseases including Alzheimer's. The blood-brain barrier protects the brain from harmful chemicals, but also makes it difficult for drugs to reach the target cells. If this delivery method proves safe in humans, then we may see more effective drugs being made available for people with Alzheimer's in the future.
'More research is now needed to see if this method would be effective for people with Alzheimer's. Dementia research is desperately underfunded. To make the breakthroughs we need, we must invest now.'
Dr Susanne Sorensen
Head of Research
Alzheimer's Society